News
Zacks.com on MSN14h
Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock?Recursion Pharmaceuticals (RXRX) saw its shares surge in the last session with trading volume being higher than average. The ...
Zacks.com on MSN4d
Recursion Pharmaceuticals Rises 6% in a Month: How to Play the StockRXRX gains 5.5% in a month on positive pipeline update; long-term hold advised given strong potential of its AI-driven drug discovery platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback